Evidence map›Paper›PMID 32641830›Full record

ArticleNature2020

A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.

Beverly Y Mok, Marcos H de Moraes, Jun Zeng, Dustin E Bosch, Anna V Kotrys, Aditya Raguram, FoSheng Hsu, Matthew C Radey, S Brook Peterson, Vamsi K Mootha and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 457 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
457citing papers in PubMed, 1 pooled it
34.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

457 citing papers in PubMed, 1 synthesis or guideline pooled it, 693 citations in OpenAlex.

  1. Pooled it
  2. Base Editing: Mechanisms and Therapeutic Applications.Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Hypertensive mt. tRNARedox biology · 2026
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

397 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Beverly Y Mok *Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Marcos H de Moraes *Department of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.
Jun ZengDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.
Dustin E BoschDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-7430-2939
Anna V KotrysHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4983-1414
Aditya RaguramMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
FoSheng HsuDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.
Matthew C RadeyDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.
S Brook PetersonDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA, USA.
Vamsi K MoothaHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Joseph D MougousDepartment of Microbiology, University of Washington School of Medicine, Seattle, WA, USA. mougous@uw.edu.
David R LiuMerkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA. drliu@fas.harvard.edu.ORCID http://orcid.org/0000-0002-9943-7557
University of Washington · USBroad Institute · USHoward Hughes Medical Institute · US

Funding

Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human DiseaseRM1HG009490 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Brittany S. Adamson, Martin Joseph Ankrah Aryee · 2017 to 2026
$22.7M
Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss · 2010 to 2026
$21.4M
Type VI secretion effectors and interbacterial competition in vivoR01AI080609 · NIAID · YALE UNIVERSITY · PI MOUGOUS, JOSEPH DAVID · 2009 to 2025
$6.7M
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel TherapeuticsR35GM118062 · NIGMS · HARVARD UNIVERSITY · PI LIU, DAVID R · 2016 to 2025
$6.4M
Mitochondrial Parts, Pathways, and PathogenesisR35GM122455 · NIGMS · BROAD INSTITUTE, INC. · PI MOOTHA, VAMSI KRISHNA · 2017 to 2021
$4.0M
Principles of Scientific Citizenship: Ethics, Communication, and Leadership for ScientistsT32GM095450 · NIGMS · HARVARD UNIVERSITY · PI WALKER, SUZANNE · 2011 to 2020
$3.5M
Expanding the Scope of Base EditingU01AI142756 · NIAID · BROAD INSTITUTE, INC. · PI LIU, DAVID R · 2018 to 2022
$2.1M
Howard Hughes Medical InstituteNHGRI NIH HHS RM1 HG009490NIAID NIH HHS R01 AI080609NIAID NIH HHS U01 AI142756NIDDK NIH HHS P30 DK089507NIGMS NIH HHS R35 GM118062NIGMS NIH HHS R35 GM122455NIGMS NIH HHS T32 GM095450
6 · The paper itself

Abstract

Bacterial toxins represent a vast reservoir of biochemical diversity that can be repurposed for biomedical applications. Such proteins include a group of predicted interbacterial toxins of the deaminase superfamily, members of which have found application in gene-editing techniques

Indexed as

Bacterial ToxinsBase SequenceBurkholderia cenocepaciaCell RespirationCytidineCytidine DeaminaseDNA, MitochondrialGene EditingGenes, MitochondrialGenome, MitochondrialHEK293 CellsHumansMitochondriaMitochondrial DiseasesMutationOxidative PhosphorylationBacterial ToxinsCytidineCytidine DeaminaseDNA, MitochondrialRNA, Guide, CRISPR-Cas SystemsType VI Secretion Systems

Identifiers

PMID32641830
PMCPMC7381381
OpenAlexW3041877641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.